Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Antimalarial Medication Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Plasmodium Falciparum
  • 1.3.3 Plasmodium Malariae
  • 1.3.4 Plasmodium Vivax
  • 1.3.5 Plasmodium Ovale
• 1.4 Market Segment by Application
  • 1.4.1 Global Antimalarial Medication Market Share by Application (2019-2025)
  • 1.4.2 Hospital Pharmacy
  • 1.4.3 Retail Pharmacy
  • 1.4.4 E- Commerce
  • 1.4.5 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Antimalarial Medication Market Size
  • 2.1.1 Global Antimalarial Medication Revenue 2014-2025
  • 2.1.2 Global Antimalarial Medication Sales 2014-2025
• 2.2 Antimalarial Medication Growth Rate by Regions
  • 2.2.1 Global Antimalarial Medication Sales by Regions 2014-2019
  • 2.2.2 Global Antimalarial Medication Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Antimalarial Medication Sales by Manufacturers
  • 3.1.1 Antimalarial Medication Sales by Manufacturers 2014-2019
  • 3.1.2 Antimalarial Medication Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Antimalarial Medication Revenue by Manufacturers (2014-2019)
  • 3.2.2 Antimalarial Medication Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Antimalarial Medication Market Concentration Ratio (CR5 and HHI)
• 3.3 Antimalarial Medication Price by Manufacturers
• 3.4 Key Manufacturers Antimalarial Medication Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Antimalarial Medication Market
• 3.6 Key Manufacturers Antimalarial Medication Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Plasmodium Falciparum Sales and Revenue (2014-2019)
  • 4.1.2 Plasmodium Malariae Sales and Revenue (2014-2019)
  • 4.1.3 Plasmodium Vivax Sales and Revenue (2014-2019)
  • 4.1.4 Plasmodium Ovale Sales and Revenue (2014-2019)
• 4.2 Global Antimalarial Medication Sales Market Share by Type
• 4.3 Global Antimalarial Medication Revenue Market Share by Type
• 4.4 Antimalarial Medication Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Antimalarial Medication Sales by Application

6 United States

• 6.1 United States Antimalarial Medication Breakdown Data by Company
• 6.2 United States Antimalarial Medication Breakdown Data by Type
• 6.3 United States Antimalarial Medication Breakdown Data by Application

7 European Union

• 7.1 European Union Antimalarial Medication Breakdown Data by Company
• 7.2 European Union Antimalarial Medication Breakdown Data by Type
• 7.3 European Union Antimalarial Medication Breakdown Data by Application

8 China

• 8.1 China Antimalarial Medication Breakdown Data by Company
• 8.2 China Antimalarial Medication Breakdown Data by Type
• 8.3 China Antimalarial Medication Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Antimalarial Medication Breakdown Data by Company
• 9.2 Rest of World Antimalarial Medication Breakdown Data by Type
• 9.3 Rest of World Antimalarial Medication Breakdown Data by Application
• 9.4 Rest of World Antimalarial Medication Breakdown Data by Countries
  • 9.4.1 Rest of World Antimalarial Medication Sales by Countries
  • 9.4.2 Rest of World Antimalarial Medication Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 GlaxoSmithKline
  • 10.1.1 GlaxoSmithKline Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Antimalarial Medication
  • 10.1.4 Antimalarial Medication Product Introduction
  • 10.1.5 GlaxoSmithKline Recent Development
• 10.2 F. Hoffmann-La Roche
  • 10.2.1 F. Hoffmann-La Roche Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Antimalarial Medication
  • 10.2.4 Antimalarial Medication Product Introduction
  • 10.2.5 F. Hoffmann-La Roche Recent Development
• 10.3 Novartis
  • 10.3.1 Novartis Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Antimalarial Medication
  • 10.3.4 Antimalarial Medication Product Introduction
  • 10.3.5 Novartis Recent Development
• 10.4 Pfizer
  • 10.4.1 Pfizer Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Antimalarial Medication
  • 10.4.4 Antimalarial Medication Product Introduction
  • 10.4.5 Pfizer Recent Development
• 10.5 Sun Pharmaceutical Industries
  • 10.5.1 Sun Pharmaceutical Industries Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Antimalarial Medication
  • 10.5.4 Antimalarial Medication Product Introduction
  • 10.5.5 Sun Pharmaceutical Industries Recent Development
• 10.6 Merck
  • 10.6.1 Merck Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Antimalarial Medication
  • 10.6.4 Antimalarial Medication Product Introduction
  • 10.6.5 Merck Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Antimalarial Medication Sales Channels
  • 11.2.2 Antimalarial Medication Distributors
• 11.3 Antimalarial Medication Customers

12 Market Forecast

• 12.1 Global Antimalarial Medication Sales and Revenue Forecast 2019-2025
• 12.2 Global Antimalarial Medication Sales Forecast by Type
• 12.3 Global Antimalarial Medication Sales Forecast by Application
• 12.4 Antimalarial Medication Forecast by Regions
  • 12.4.1 Global Antimalarial Medication Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Antimalarial Medication Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.
Antimalarial medication are the medicines used to prevent and treat malaria.
In 2019, the market size of Antimalarial Medication is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antimalarial Medication.

This report studies the global market size of Antimalarial Medication, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antimalarial Medication sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GlaxoSmithKline
F. Hoffmann-La Roche
Novartis
Pfizer
Sun Pharmaceutical Industries
Merck
...

Market Segment by Product Type
Plasmodium Falciparum
Plasmodium Malariae
Plasmodium Vivax
Plasmodium Ovale

Market Segment by Application
Hospital Pharmacy
Retail Pharmacy
E- Commerce
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Antimalarial Medication status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antimalarial Medication manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Antimalarial Medication are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025